Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_assertion type Assertion NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_head.
- NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_assertion description "[These results show that direct gene delivery of human tissue kallikrein causes a sustained reduction in systolic blood pressure in genetically hypertensive rats and indicate that the feasibility of kallikrein gene therapy for treating human hypertension should be studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_provenance.
- NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_assertion evidence source_evidence_literature NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_provenance.
- NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_assertion SIO_000772 7535795 NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_provenance.
- NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_assertion wasDerivedFrom befree-20140225 NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_provenance.
- NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_assertion wasGeneratedBy ECO_0000203 NP278448.RAeJ8LE40yYaOexwwSbrJTOyw1dipukgS23wPr2MwL1t0130_provenance.